Genomic biomarker testing
Helomics offers a select group of clinically relevant protein expression and genetic mutation tests associated with drug response and disease prognosis. Only well-validated tests are included in our biomarker menu with citations of supporting literature provided in every test report.
Panels are available for gynecologic and all other solid tumor types and can be ordered by individual biomarker.
Helomics genomic biomarkers include:
EGFR pathway
DNA repair
Angiogenesis
Additional markers
Results are available within 10-14 days of receiving a signed test order form.

Utilizing biomarker results
Helomics biomarker results are presented in a clear, easy-to-understand format, including summaries of the clinical relevance of each test. Each patient report is delivered within 10-14 days of receiving a signed test order form.
Useful, easy to read information.
- Clinically Relevant: Only markers relevant to your patient’s cancer type are included
- Literature references provided, demonstrating link between marker and therapy
- Well validated: All markers have strong clinical evidence supporting their use: many are included in guidelines
- Results can be used in both the primary and recurrent settings
